Home » Topics » BioWorld Science

BioWorld Science
RSS

Bexson expands ketamine patch pump program into depression

Nov. 19, 2021

Biopolar Hongye (Nantong) Pharmaceutical synthesizes JAK2 inhibitors

Nov. 19, 2021

Chinese researchers synthesize new phosphodiesterase PDE4 inhibitors

Nov. 19, 2021

Beijing Tide Pharmaceutical identifies GTPase KRAS inhibitors

Nov. 19, 2021

Betta Pharmaceuticals patents new compounds for cancer

Nov. 19, 2021

Hangzhou Innogate Pharma divulges SYK and JAK2 kinase inhibitors

Nov. 19, 2021

SGN-PDL1V, a PD-L1-directed ADC with activity in multiple tumor xenograft models

Nov. 19, 2021

Antibody-drug conjugate SGN-B7H4V shows promise in preclinical models of cancer

Nov. 19, 2021

Rat model for PD using AAV-induced overexpression of E46K-like alphaSYN mutants

Nov. 19, 2021

Anti-PD-L1 IGM-7354 shows promise for cancer immunotherapy

Nov. 19, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026